OncoSec Medical Inc (ONCSQ)

[lasers]

A year ago $ONCS presented their new trial data at ASCO via a Poster Presentation for EP+IL-12

http://meetinglibrary.asco.org/content/134277-144

This year $ONCS presented their new , in my assumption, data at the New York Academy of Sciences via a Poster Presentation for IL-12 biologic pathways. "Intratumoral Expression of Plasmid IL-12 Can Increase CD8 TILs and Drive Systemic Anti-Tumor Responses"

Dr. Pierce IMO is trying to develop/find biologic markers that will quickly identify and allow for maximizing IL-12 dosage for each individual cancer recipient at their dosing session. IL-12 dosages are toxic if too high, produce good ORR for small dosages and could possibly produce excellent increased ORR when optimized identified by new found biologic markers.

If Dr. Pierce is successful at optimizing IL-12 dosages then this would be important new data discovery and worthy of 1st time public presentation as detemined by the New York Academy of Sciences.

We await now for full release of the Poster details.